Heart Tumor
Symptoms, Doctors, Treatments, Advances & More

Heart Tumor Overview

Save information for later
Sign Up

Learn About Heart Tumor

What is the definition of Heart Tumor?
A heart tumor, also known as a cardiac tumor, is a growth in the heart that can be either cancerous (malignant) or non-cancerous (benign). A heart tumor can originate in the heart (primary), also known as a myxoma, or spread from another part of the body (secondary).
What are the symptoms of Heart Tumor?
Some individuals with a heart tumor may not have any symptoms. Symptoms of heart tumor may include fever; cough weight loss; anemia; chest pain; blue fingers; enlarged fingers; curved nails; joint pain; difficulty breathing when lying flat; dizziness; fainting; irregular heartbeat; swelling of the abdomen, ankles, or legs; fluid around the heart; and stroke.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Heart Tumor?
Treatment for heart tumor involves a multidisciplinary team of specialists and may include surgery, chemotherapy, radiation, placement of a left ventricular assist device (LVAD), heart reconstructive surgery, artificial heart, or heart transplantation.
Who are the top Heart Tumor Local Doctors?
Elite in Heart Tumor
Dr. Richard Steingart
Cardiology
Elite in Heart Tumor
Dr. Richard Steingart
Cardiology

Memorial Sloan Kettering Cancer Center

1275 York Ave, 
New York,, NY 
212-639-2000
Languages Spoken:
English
See accepted insurances

Richard Steingart is a Cardiologist practicing medicine in New York,, New York. Dr. Steingart is rated as an Elite provider by MediFind in the treatment of Heart Tumor. He is also highly rated in 5 other conditions, according to our data. His clinical expertise encompasses Heart Tumor, Cardiomyopathy Due to Anthracyclines, Doxorubicin-Induced Cardiomyopathy, and Cardiomyopathy.

Elite in Heart Tumor
Dr. Kyle Klarich
Cardiology
Elite in Heart Tumor
Dr. Kyle Klarich
Cardiology

MN - Heart Carditis

200 1st St SW, 
Rochester, MN 
507-923-2592
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Kyle Klarich is a Cardiologist practicing medicine in Rochester, Minnesota. Dr. Klarich is rated as an Elite provider by MediFind in the treatment of Heart Tumor. She is also highly rated in 13 other conditions, according to our data. Her clinical expertise encompasses Heart Tumor, Hypertrophic Cardiomyopathy (HCM), Familial Hypertrophic Cardiomyopathy, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Heart Tumor
Dr. Jonathan Weinsaft
Cardiology
Elite in Heart Tumor
Dr. Jonathan Weinsaft
Cardiology

Radiology At NewYork-Presbyterian/Weill Cornell Medical Center

525 E 68th St, 
New York, NY 
347-719-4768
Languages Spoken:
English
See accepted insurances

Jonathan Weinsaft is a Cardiologist practicing medicine in New York, New York. Dr. Weinsaft is rated as an Elite provider by MediFind in the treatment of Heart Tumor. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Heart Tumor, Mitral Valve Regurgitation, Marfan Syndrome, Aortic Valve Replacement, and Heart Bypass Surgery.

View All Doctors
What are the latest Heart Tumor Clinical Trials?
Health Warnings and Counseling at Primary Health Care Centers for Smoking Cessation and NCD Prevention: A Randomized Controlled Trial in Bangladesh and Pakistan
Health Warnings and Counseling at Primary Health Care Centers for Smoking Cessation and NCD Prevention: A Randomized Controlled Trial in Bangladesh and Pakistan
Enrollment Status: Recruiting
Publish Date: April 14, 2026
Intervention Type: Behavioral, Other
Study Phase: Not Applicable

Summary: Tobacco use remains persistently high across South Asia, despite numerous public health efforts, and continues to significantly contribute to the burden of non-communicable diseases (NCDs) such as cardiovascular disease, hypertension, diabetes, and stroke. Community pharmacists-widely accessible and trusted within their communities-are an underutilized resource for delivering public health interve...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria
Efficacy and Safety Comparison of Short-course Radiotherapy Followed by CapeOX Chemotherapy Plus Toripalimab With or Without Concurrent Surufatinib in Neoadjuvant Therapy for Mid-to-low Localized Rectal Cancer of High-risk Criteria
Enrollment Status: Recruiting
Publish Date: April 01, 2026
Intervention Type: Drug
Study Phase: Phase 2/Phase 3

Summary: Why is this study conducted? The purpose of this study is to improve the treatment efficacy, particularly the pathological complete response rate, in patients with high-risk/extremely high-risk locally advanced rectal cancer (LARC). In recent years, with the combination of neoadjuvant chemoradiotherapy and immunotherapy, some progress has been made in the treatment of rectal cancer, but there are ...

View All Clinical Trials